Skip to main content
SpringerLink
Log in

Risperidone diminishes cocaine-induced craving

  • Letter to the editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • Brauer LH, Rukstalis MR, de Wit H (1995) Acute subjective responses to paroxetine in normal volunteers. Drug Alcohol Depend 39:223–230

    Article  CAS  PubMed  Google Scholar 

  • Brauer LH, Ambre J, De Wit H (1996) Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men. J Clin Psychopharmacol 16:72–76

    Article  CAS  PubMed  Google Scholar 

  • Broderick PA, Rahni DN, Zhou Y (2003) Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. Prog Neuropsychopharmacol Biol Psychiatry 27:1037–1054

    Article  CAS  PubMed  Google Scholar 

  • Carroll ME, Comer SD (1996) Animal models of relapse. Exp Clin Psychopharmacol 4:11–18

    Article  CAS  Google Scholar 

  • De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ (1999) Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 143:254–260

    Article  Google Scholar 

  • Ehrman RN, Robbins SJ, Childress AR, O’Brien CP (1992) Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 107:523–529

    CAS  PubMed  Google Scholar 

  • Fletcher PJ (1998) A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine. Pharmacol Biochem Behav 60:55–60

    Article  CAS  PubMed  Google Scholar 

  • Foltin RW, Fischman MW (1998) Effects of “binge” use of intravenous cocaine in methadone-maintained individuals. Addiction 93:825–836

    Article  CAS  PubMed  Google Scholar 

  • Foltin RW, Ward AS, Haney M, Hart CL, Collins ED (2003) The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend 70:149–157

    Article  CAS  PubMed  Google Scholar 

  • Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, Bailey R (2000) Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol 20:305–310

    Article  CAS  PubMed  Google Scholar 

  • Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29:969–981

    Article  CAS  PubMed  Google Scholar 

  • Haney M, Ward AS, Foltin RW, Fischman MW (2001) Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 155:330–337

    Article  CAS  Google Scholar 

  • Houtsmuller EJ, Notes LD, Newton T, van Sluis N, Chiang N, Elkashef A, Bigelow GE (2004) Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl) 172:31–40

    Article  CAS  Google Scholar 

  • Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology 97:59–64

    CAS  PubMed  Google Scholar 

  • Kapur S, Remington G, Zipursky RB, Wilson AA, Houle S (1995) The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci 57:L103–L107

    Article  Google Scholar 

  • Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD (2000) Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294:680–687

    CAS  PubMed  Google Scholar 

  • Kosten TR, George TP, Kosten TA (2002) The potential of dopamine agonists in drug addiction. Expert Opin Investig Drugs 11:491–499

    CAS  PubMed  Google Scholar 

  • Kuroki T, Meltzer HY, Ichikawa J (1999) Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288:774–781

    CAS  PubMed  Google Scholar 

  • Lukas SE, Sholar M, Lundahl LH, Lamas X, Kouri E, Wines JD, Kragie L, Mendelson JH (1996) Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl) 125:346–354

    CAS  Google Scholar 

  • Newton TF, Kalechstein A, Beckson M, Bartzokis G, Bridge TP, Ling W (1999) Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatry Res 87:101–106

    Article  CAS  PubMed  Google Scholar 

  • Newton TF, Ling W, Kalechstein AD, Uslaner J, Tervo K (2001) Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Res 102:227–233

    Article  CAS  PubMed  Google Scholar 

  • Ohuoha DC, Maxwell JA, Thomson LE III, Cadet JL, Rothman RB (1997) Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case study. J Subst Abuse Treat 14:249–258

    Article  CAS  PubMed  Google Scholar 

  • Preston KL, Sullivan JT, Strain EC, Bigelow GE (1992) Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 262:279–291

    CAS  PubMed  Google Scholar 

  • Romach MK, Glue P, Kampman K, Kaplan HL, Somer GR, Poole S, Clarke L, Coffin V, Cornish J, O’Brien CP, Sellers EM (1999) Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) [see comments]. Arch Gen Psychiatry 56:1101–1106

    Article  CAS  PubMed  Google Scholar 

  • Rush CR, Stoops WW, Hays LR, Glaser PE, Hays LS (2003) Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306:195–204

    Article  CAS  PubMed  Google Scholar 

  • Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D (2002) Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry 47:671–675

    PubMed  Google Scholar 

  • Soares BG, Lima MS, Reisser AA, Farrell M (2003) Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev CD003352

  • Spitzer R, Williams J, Gibbon M (1995) Structured clinical interview for DSM-IV (SCID). New York State Psychiatric Institute: Biometrics Research, New York

    Google Scholar 

  • Stewart J, de Wit H, Eikelboom R (1984) Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251–268

    Article  CAS  PubMed  Google Scholar 

  • Tsuang JW, Eckman T, Marder S, Tucker D (2002) Can risperidone reduce cocaine use in substance abusing schizophrenic patients? J Clin Psychopharmacol 22:629–630

    Article  CAS  PubMed  Google Scholar 

  • Uslaner J, Kalechstein A, Richter T, Ling W, Newton T (1999) Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am J Psychiatry 156:1444–1446

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported in part by grants to T.F.N. from the National Institute of Health (DA50038, DA00388, DA07272, M01 RR00865).

Author information

Authors and Affiliations

  1. Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Neuropsychiatric Institute, Los Angeles, CA, 90024, USA

    Richard De La Garza II, Thomas F. Newton & Ari D. Kalechstein

Authors
  1. Richard De La Garza II
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas F. Newton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ari D. Kalechstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard De La Garza II.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De La Garza, R., Newton, T.F. & Kalechstein, A.D. Risperidone diminishes cocaine-induced craving. Psychopharmacology 178, 347–350 (2005). https://doi.org/10.1007/s00213-004-2010-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-2010-8

Keywords

Search

Navigation